Läkemedel Infliximab 2024
Buyer: Region Blekinge
- Published
- 13 January 2025
- Estimated value
- 13,000,000 kr
- Place of performance
- SE221
- Procedure
- Open procedure
- Lots
- 1
- Notice number
- 00020411-2025
- Reference
- 0c45ee5e-bcd6-40c1-a4b7-27dfebc94ba5
- Official source
- Official source
CPV codes
- 33600000Productos farmacéuticos
Description
Läkemedel Infliximab
Award criteria
- Price
Awards
| Awarded to | Amount | Date |
|---|---|---|
| Sandoz A/S | — | — |
| Orion Pharma AB | — | — |
| Janssen-Cilag AB | — | — |
| Biogen Sweden AB | — | — |
Official publications
- TED · 00020411-2025 · 13 January 2025
- OJS · 8/2025 · 13 January 2025
Other tenders from Region Blekinge
- Andningsbehandlingshjälpmedel
- Digitala röntgensensorer för Folktandvården
- Dental utrustning till specialisttandvården 2026
- Truckar till nya centrallagret
- Laser för urologi
- Ramavtal ultraljud klinisk fysiologi och thorax
- Frivillig förhandsinsyn - ett (1) styck blodgasinstrument
- Osteosyntesmaterial 2026
- Ultraljud till mammografi
- Gynekologitjänster 2026
Frequently asked questions
- What is the estimated value of this tender?
- The estimated value published by the buyer is 13,000,000 kr.
- Who is the buyer of this tender?
- The contracting authority is Region Blekinge (European Union).
- How can I bid for public tenders in European Union?
- Bids are submitted through the official procurement portal of European Union. El Vínculo helps you find tenders and analyse their documents; submission always happens at the official source.
Get alerts for tenders like this
Create a free account and receive new tenders from European Union matching your business, every day.
Create a free account and receive new tenders from European Union matching your business, every day.